ENVB on Nasdaq

Enveric Biosciences, Inc.

Enveric Biosciences is a biotechnology company.1

Price unavailable

Last updated Oct 18, 2026.

Overview

Compare with Equillium, Inc., Biofrontera Inc. or BGM Group Ltd., or pick any stock.

  • TickerENVB on Nasdaq1
  • IndustryPharmaceutical Preparations1
  • HeadquartersDE1
  • Incorporated inDE3
  • Business address245 First Street Riverview Ii 18Th Floor, Cambridge, Ma 021423
  • Filer categoryNon-accelerated filer, Smaller reporting company3

See how the biggest companies compare on our leaderboards

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2019

20.4%Gross margin4
-5.8%Operating margin5
-6.0%Net margin5

Where the money goes

Where each dollar of revenue went, fiscal 2019

  • Cost of revenue80¢$31.8M
  • Selling, general and admin6¢$2.3M
  • Other costs13¢$5.4M
  • Interest0¢$81.8K
  • Income tax1¢$388.7K

Out of $39.9M in revenue.45 The company lost money this year.

Financial statements

Every line of the income statement as filed: the last 2 fiscal years, latest first.8

Period ending2025-12-312024-12-31
General and administrative$5.8M$6.5M
Research and development$2.8M$2.8M
Depreciation and amortization$200.9K$337.5K
Total operating expenses$8.8M$9.6M
Loss from operations-$8.8M-$9.6M
Other income$2.6K$66.0K
Interest (expense) income, net-$106$219
Total other income$2.5K$66.2K
Net loss before income taxes-$8.8M-$9.6M
Income tax expense-$8.9K
Net loss-$8.8M-$9.6M
Less deemed dividend on inducement of warrants$3.4M
Net loss attributable to shareholders-$12.1M-$9.6M
Foreign currency translation$14.5K-$24.8K
Comprehensive loss-$8.8M-$9.6M
Net loss per share - basic-$36.24-$228.48
Net loss per share - diluted-$36.24-$228.48
Weighted average shares outstanding, basic334.7K shares41.9K shares
Weighted average shares outstanding, diluted334.7K shares41.9K shares

Compare Enveric Biosciences, Inc. with another company

Leadership

Who has led Enveric Biosciences, Inc., and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. Jay Gottlieb2009–2012
  2. Jeffrey E. Eberwein2013–2014
  3. Giri Devanur2015–2017
  4. Brent Kelton2018–2019
  5. David Ian Johnson2021
  6. Joseph Edward Tucker2021–now

Chair

  1. Jeffrey E. Eberwein2013–2014
  2. David Ian Johnson2021

President

  1. Jeffrey E. Eberwein2013–2014
  2. Giri Devanur2015–2017
  3. Avani Kanubaddi2022–2023

Chief financial officer

  1. Greggory A. Schneider2009–2012
  2. Jeffrey E. Eberwein2013–2014
  3. Viraj J. Patel2017–2018
  4. Barry Kostiner2018
  5. Buiten John Van2021
  6. Carter Julian Ward2021–2022
  7. Kevin Michael Coveney2023–now

Chief operating officer

  1. Avani Kanubaddi2021–2023
2010201520202025
Board members and other officers (33)

Former names

  • AMERI Holdings, Inc.May 28, 2015 to Dec 30, 20203
  • SPATIALIZER AUDIO LABORATORIES INCSep 16, 1996 to May 27, 20153

Timeline

  1. Sep 27, 2021New chief executive Joseph Edward Tucker becomes CEO11
  2. Jan 8, 2021New chief executive David Ian Johnson becomes CEO10
  3. Jan 11, 2018New chief executive Brent Kelton becomes CEO12
  4. Jun 3, 2015New chief executive Giri Devanur becomes CEO13
  5. Dec 4, 2013New chief executive Jeffrey E. Eberwein becomes CEO14
  6. Jul 13, 2009New chief executive Jay Gottlieb becomes CEO15

Filings

332 filings to the SEC since October 2021: 6 annual reports, 15 quarterly reports, 124 major events, 51 insider forms, 32 large holders, 6 private raises, 98 other. The latest 20:

  1. Aug 14, 202610-Q EDGAR
  2. Aug 14, 20268-K EDGAR
  3. Aug 14, 2026SCHEDULE 13G EDGAR
  4. Aug 14, 2026SCHEDULE 13G/A EDGAR
  5. Aug 13, 2026SCHEDULE 13G/A EDGAR
  6. Jun 9, 20268-K EDGAR
  7. Jun 9, 2026424B5 EDGAR
  8. Jun 9, 20268-K EDGAR
  9. Jun 3, 20264 EDGAR
  10. Jun 3, 20264 EDGAR
  11. Jun 3, 20264 EDGAR
  12. Jun 3, 20264 EDGAR
  13. Jun 3, 20264 EDGAR
  14. Jun 3, 20264 EDGAR
  15. Jun 3, 20264 EDGAR
  16. Jun 3, 20264 EDGAR
  17. Jun 1, 2026S-8 EDGAR
  18. May 29, 20268-K EDGAR
  19. May 15, 202610-Q EDGAR
  20. May 15, 20268-K EDGAR

The 332 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last three years, summarized. The full record is on SEC EDGAR.

Insider trades and holders

Large holders

Investors who own more than 5% must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively. 32 such filings since October 2021, the latest 10:

  1. Aug 14, 2026SCHEDULE 13G
  2. Aug 14, 2026SCHEDULE 13G/A
  3. Aug 13, 2026SCHEDULE 13G/A
  4. May 15, 2026SCHEDULE 13G/A
  5. Feb 4, 2026SCHEDULE 13G
  6. Feb 2, 2026SCHEDULE 13G
  7. Jan 5, 2026SCHEDULE 13G/A
  8. Dec 17, 2025SCHEDULE 13G
  9. Dec 10, 2025SCHEDULE 13G/A
  10. Dec 10, 2025SCHEDULE 13G/A

From Forms 4 and Schedules 13D and 13G filed with the SEC.

Money raised

Private offerings the company reported to the SEC on Form D.

  1. Apr 17, 2026Raised $5 million in a private offering of equity Form D: 4 investors so far Form D
  2. Jan 28, 2026Raised $1.5 million in a private offering of securities Form D: 5 investors so far Form D
  3. Dec 12, 2025Raised $106,598 in a private offering of securities Form D: 15 investors so far Form D
  4. Sep 18, 2025Filed a private offering of securities Form D: 12 investors so far Form D
  5. Jul 22, 2022Raised $12.8 million in a private offering of equity Form D: 2 investors so far Form D

Held by these funds

The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026. Change is in shares since the quarter before.

FundSharesValueShare of the fundChange
Sio Capital Management, LLC180,000$248.4K0.0%New
Ikarian Capital, LLC100,002$138.0K0.0%New
AdvisorShares Investments LLC35,417$48.9K0.0%+18,443
Renaissance Technologies LLC32,058$44.2K0.0%New
Armistice Capital, LLC32,000$44.2K0.0%New
Boothbay Fund Management, LLC30,142$41.6K0.0%New
XTX Topco Ltd18,990$26.2K0.0%New
StoneX Group Inc.11,814$21.9K0.0%New
Vanguard Capital Management LLC14,912$20.6K0.0%New
Citadel Advisors LLC13,965$19.3K0.0%New
Geode Capital Management, LLC11,794$16.3K0.0%−20,355
Morgan Stanley10,733$14.8K0.0%New
Tower Research Capital LLC (TRC)4,984$6.9K0.0%+3,881
SBI Securities Co., Ltd.2,676$3.7K0.0%+2,593
Jones Financial Companies Lllp1,000$1.4K0.0%No change
Integrated Wealth Concepts LLC702$9690.0%New
UBS Group AG201$2770.0%−3,411
BlackRock, Inc.51$700.0%No change
Hrt Financial LP15,458$210.0%New
Virtu Financial LLC10,690$150.0%New
Wells Fargo & Company/mn1$10.0%No change
Danske Bank A/s1$10.0%No change
National Bank Of Canada /fi/1$10.0%No change
Osaic Holdings, Inc.1$10.0%New

13F reports cover disclosed long positions in U.S. stocks only.

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35
  36. 36
  37. 37
  38. 38
  39. 39
  40. 40
  41. 41
  42. 42
  43. 43
  44. 44
  45. 45
  46. 46
  47. 47
  48. 48
  49. 49
  50. 50
  51. 51
  52. 52
  53. 53